Hematology/Oncology

Top Story

One hour of physical activity offsets increased risk of death from sitting

July 29, 2016

About 60 to 75 minutes of moderate intensity physical activity negated the increased risk for death associated with sitting for 8 hours each day, according to findings published in The Lancet.

Ulf Ekelund, PhD, professor at the Norwegian School of Sport Sciences, in Oslo, and colleagues also reported that this level of activity mitigates, but does not completely offset, the increased risk for death associated with long periods of watching television.

In the Journals Plus

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016
Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer, according to a subgroup…
In the Journals Plus

Thyroid cancer risk increases with hysterectomy

July 29, 2016
Among postmenopausal women, the risk for thyroid cancer is increased with hysterectomy regardless of oophorectomy status, according to recently published data. Use of…

American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy

July 29, 2016
The American Society of Breast Surgeons issued a position statement that recommends against contralateral prophylactic mastectomy for average-risk women with unilateral…
In the Journals Plus

Ovarian cancer surveillance with CA-125 tests, CT scans common despite lack of proven benefit

July 29, 2016
Cancer antigen 125 tests and CT scans are routinely used for surveillance of patients with ovarian cancer despite a lack of proven benefit, according to results of a…
More News Headlines »
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video

VIDEO: James L. M. Ferrara, MD, DSc, reviews “long-standing problem” of GVHD after allogeneic HSCT

July 14, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan